InflaRx gets EU okay for Gohibic for COVID-19 respiratory distress InflaRx gets EU okay for Gohibic for COVID-19 respiratory distress Post ContentifrxRead More You might also be interested in reading Criteo S.A. Q2 2025 Earnings Preview. January 15, 2025 In Mainstream ← Previous post Next post →